Skip to main content
Clinical Trials/ChiCTR2200060369
ChiCTR2200060369Active, not recruitingPhase 4

术中雾化沙丁胺醇对小儿扁桃体切除术术中及术后呼吸道并发症发生率的影响

泰州市人民医院1 site in 1 country164 target enrollmentStarted: May 18, 2022Last updated:

Trial Snapshot

Phase
Phase 4
Status
Active, not recruiting
Sponsor
Enrollment
164
Locations
1
Primary Endpoint
呼吸道并发症

Study Overview

Brief Summary

研究术中给予沙丁胺醇雾化,能否减少小儿术中及术后气道并发症的发生率、能否提高围手术期呼吸道安全性及改善预后。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照

Eligibility Criteria

Ages
4 to 14 (—)
Sex
All

Inclusion Criteria

  • ASA 分级 I-II 级;

Exclusion Criteria

  • 严重的心肺功能障碍、严重肝肾功能不全、神经精神系统疾病、药物滥用;
  • BMI 值≥30kg/m2;
  • 对麻醉用药中任意一种过敏、有沙丁胺醇相关禁忌征者;
  • 术前氧饱和度低于 95%,或存在气道畸形者;

Arms & Interventions

实验组

雾化沙丁胺醇

对照组

雾化生理盐水

Outcomes

Primary Outcomes

呼吸道并发症

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
泰州市人民医院

Study Sites (1)

Loading locations...

Similar Trials